Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 1531 AL 1545

Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review

Evans EC, Matteson KA, Orejuela FJ, Alperin M, Balk EM, El-Nashar S, Gleason JL, Grimes C, Jeppson P, Mathews C, Wheeler TL, Murphy M; Society of Gynecologic Surgeons Systematic Review Group.

Obstet Gynecol. 2016 Sep;128(3):476-85. doi: 10.1097/AOG.0000000000001592.

Machine learning for large-scale wearable sensor data in Parkinson's disease: Concepts, promises, pitfalls, and futures

Kubota KJ, Chen JA, Little MA.

Mov Disord. 2016 Sep;31(9):1314-26. doi: 10.1002/mds.26693. Epub 2016 Aug 8.

Moving Parkinson care to the home

Dorsey ER, Vlaanderen FP, Engelen LJ, Kieburtz K, Zhu W, Biglan KM, Faber MJ, Bloem BR.

Mov Disord. 2016 Sep;31(9):1258-62. doi: 10.1002/mds.26744. Epub 2016 Aug 8.

Parkinson Disease and Dementia

Garcia-Ptacek S, Kramberger MG.

J Geriatr Psychiatry Neurol. 2016 Sep;29(5):261-70. doi: 10.1177/0891988716654985.

PARL: The mitochondrial rhomboid protease

Spinazzi M, De Strooper B.

Semin Cell Dev Biol. 2016 Dec;60:19-28. doi: 10.1016/j.semcdb.2016.07.034. Epub 2016 Aug 5.

Massage therapy research review

Field T.

Complement Ther Clin Pract. 2016 Aug;24:19-31. doi: 10.1016/j.ctcp.2016.04.005. Epub 2016 Apr 23.

Yoga research review

Field T.

Complement Ther Clin Pract. 2016 Aug;24:145-61. doi: 10.1016/j.ctcp.2016.06.005. Epub 2016 Jun 16.

Prodromal symptoms of Parkinson's disease: Implications for epidemiological studies of disease etiology

Elbaz A.

Rev Neurol (Paris). 2016 Aug-Sep;172(8-9):503-511. doi: 10.1016/j.neurol.2016.07.001. Epub 2016 Aug 5.

Hypnosis and movement disorders: State of the art and perspectives

Flamand-Roze C, Célestin-Lhopiteau I, Roze E.

Rev Neurol (Paris). 2016 Aug-Sep;172(8-9):530-536. doi: 10.1016/j.neurol.2016.07.008. Epub 2016 Aug 5.

The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's Disease

Divac N, Stojanović R, Savić Vujović K, Medić B, Damjanović A, Prostran M.

Behav Neurol. 2016;2016:4938154. doi: 10.1155/2016/4938154. Epub 2016 Jul 18.

Intranodal Palisaded Myofibroblastoma: Radiological and Cytological Overview

Altinbas NK, Oz I, Ustuner E, Gulpinar B, Peker E, Akkaya Z, Peker A, Ceyhan K, Yagci C.

Pol J Radiol. 2016 Jul 22;81:342-6. doi: 10.12659/PJR.895743. eCollection 2016.

Side effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacology

Borovac JA.

Yale J Biol Med. 2016 Mar 24;89(1):37-47. eCollection 2016 Mar.

The Significance of the Default Mode Network (DMN) in Neurological and Neuropsychiatric Disorders: A Review

Mohan A, Roberto AJ, Mohan A, Lorenzo A, Jones K, Carney MJ, Liogier-Weyback L, Hwang S, Lapidus KA.

Yale J Biol Med. 2016 Mar 24;89(1):49-57. eCollection 2016 Mar.

Progress Regarding Parkinson's Disease Psychosis: It's No Illusion

Weintraub D.

Mov Disord Clin Pract. 2016 Aug 11;3(5):431-434. doi: 10.1002/mdc3.12377. eCollection 2016 Sep-Oct.

Evolution of clinical features in possible DLB depending on FP-CIT SPECT result

Walker Z, Moreno E, Thomas A, Inglis F, Tabet N, Stevens T, Whitfield T, Aarsland D, Rainer M, Padovani A; DaTSCAN DLB Phase 4 Study Group.

Neurology. 2016 Sep 6;87(10):1045-51. doi: 10.1212/WNL.0000000000003076. Epub 2016 Aug 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias